HIV 101: Fundamentals of HIV Infection and Applications of Antiretroviral Therapy

Assessment of Needs

The IAS–USA offers this introductory activity on the evolving challenges of managing HIV disease as part of a nationwide continuing medical education (CME) effort for physicians. This webinar is designed for HIV or infectious disease fellows, residents, and practitioners who are new to the field of HIV research and management. It will describe the core principles of HIV management, including epidemiology, mechanisms of action of existing drugs, initial antiretroviral regimens, and drug resistance. This webinar will also be useful to experienced clinicians who seek a review of these core principles.

Learning Objectives

On completion of this webinar, learners will be able to:

• Summarize events of early HIV infection
• List the sequence of laboratory markers following HIV acquisition
• Describe basic mechanisms of antiretroviral therapy
• Select antiretroviral therapy in patients who:
  • Are starting initial therapy
  • Have persistently low-level viremia
  • Are pregnant or considering pregnancy
  • Are experiencing virologic failure / resistance

Registration

Note: The IAS–USA acknowledges the importance of delivering the same high-quality education and resources to our audiences despite the challenging times we are experiencing due to the COVID-19 pandemic. In response, the implementation of a nominal fee to process the claim of CME and CE credits for webinars has been postponed.

Who Should Attend

This webinar is designed for clinical decision makers who are new to or actively involved in HIV care and research. It is also relevant for registered nurses, PharmDs, and other health professionals.

Individual registration is required, even if you are viewing as a group, in order to receive CME credit or a certificate of participation.

Registration closes on Monday, June 29, 2020, 4:00 PM (PT).

Certificates will be available after the completion of the evaluation and claim form.

For more information or questions, please contact the registration department at registration@iasusa.org or 415-544-9400.

Conflicts of Interest

In the interest of maintaining the independence of its CME activities, and in accordance with the policies of the Accreditation Council for Continuing Medical Education (ACCME), the IAS–USA requires all persons with control of content (eg, faculty, IAS–USA Board members, and program staff) to disclose any financial relationships that they or their spouses or partners have had with commercial companies within the past 12 months. Any real or apparent conflicts of interest of those parties are resolved prior to the CME activity being delivered. Individuals who refuse to disclose financial interests may not participate in an IAS–USA CME activity.

The ACCME defines a commercial interest as “any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests – unless the provider of clinical service is owned, or controlled by, an ACCME-defined commercial interest.”

Presenter

Dr Saag has received research grants and support awarded to his institution from Gilead Sciences, Inc and ViiV Healthcare. (Updated 3/12/20)
Dr Gandhi has served as a consultant or advisor to Merck & Co, Inc. (Updated 06/28/20)

Planner/Reviewer

Planner/Reviewer 1 has no relevant financial affiliations to disclose. (Updated 02/08/18)
Planner/Reviewer 2 has no relevant financial affiliations to disclose. (Updated 06/23/20)